NKGen Biotech to present Alzheimer’s and brain disease trial data at Korea summit
NKGen Biotech announced that Chairman and CEO Paul Y. Song, M.D., will present on troculeucel, the company’s lead investigational program, at Biologics Manufacturing Korea 2026 in Incheon on 17-18 Sept. 2026, with the presentation scheduled for 18 Sept. at 11:00 a.m. KST. The presentation will cover
<p>NKGen Biotech announced that Chairman and CEO Paul Y. Song, M.D., will present on troculeucel, the company’s lead investigational program, at Biologics Manufacturing Korea 2026 in Incheon on 17-18 Sept. 2026, with the presentation scheduled for 18 Sept. at 11:00 a.m. KST. The presentation will cover</p>